Bio-Techne Profit Margin

Bio-Techne posts a profit margin of 14.97% as of June 2026. That compares with 6.02% in the prior-year period — up 148.7% year over year. That is above the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bio-Techne's profit margin was 6.02%. The latest reading is 14.97% — a 148.7% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. Bio-Techne's 14.97% is higher that level. That is roughly 7.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Bio-Techne's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 14.97% as of June 2026; use YoY and peer views to separate noise from signal.

Context for TECH's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Bio-Techne's other metric pages and overview cover the third.